Human papillomavirus vaccine coverage in Rwanda: a population-level analysis...
In a new study published in the journal Vaccine, researchers from the International Agency for Research on Cancer (IARC) and partners from the Ministry of Health of Rwanda and Université Claude Bernard...
View ArticleImpact of human papillomavirus vaccination, Rwanda and Bhutan
Scientists from the International Agency for Research on Cancer (IARC) and partner institutions conducted a study to estimate the effectiveness of a vaccination programme against human papillomavirus...
View ArticleProfessor Cristina Stefan receives the IARC Award for Women in Cancer...
The International Agency for Research on Cancer (IARC) is pleased to announce that the inaugural recipient of the IARC Award for Women in Cancer Research is Professor Cristina Stefan, Director of the...
View ArticleHuman papillomavirus vaccine effect against human papillomavirus infection in...
A new study by researchers from the International Agency for Research on Cancer (IARC), in collaboration with the Ministry of Health of Rwanda and partner institutions, has shown that vaccination...
View ArticleLeveraging single-dose human papillomavirus vaccination dose-efficiency to...
In a new paper, researchers from the International Agency for Research on Cancer (IARC) show that adopting a single-dose schedule for vaccination against human papillomavirus (HPV), combined with...
View Article